```html

Glomerulonephritis‑related Hematuria

What is Glomerulonephritis hematuria?

Glomerulonephritis (GN) is inflammation of the tiny filtering units (glomeruli) within the kidneys. When these filters become inflamed or damaged, red blood cells can leak into the urine, a condition known as hematuria. Hematuria may appear as pink, red, or cola‑colored urine, or it may be detected only under a microscope.

In the context of GN, hematuria is a key sign that the disease is affecting the kidney’s filtration barrier. It can be gross (visible to the naked eye) or microscopic (detected only on a lab test). The presence, amount, and duration of hematuria help clinicians gauge disease activity and guide further testing.

Sources: Mayo Clinic; National Kidney Foundation.

Common Causes

Glomerulonephritis can be triggered by a variety of systemic or kidney‑specific conditions. Below are the most frequently encountered causes that can lead to hematuria:

• IgA Nephropathy (Berger disease) – deposition of IgA antibodies in the glomeruli; the most common cause of primary GN worldwide.
• Post‑infectious GN – follows infections such as streptococcal throat or skin infections (e.g., impetigo).
• Lupus nephritis – systemic lupus erythematosus (SLE) causing immune complex deposition.
• Membranous nephropathy – immune‑mediated thickening of the glomerular basement membrane.
• ANCA‑associated vasculitis (e.g., granulomatosis with polyangiitis, microscopic polyangiitis).
• Goodpasture syndrome – anti‑glomerular basement membrane antibodies that also affect the lungs.
• Alport syndrome – hereditary collagen IV defect leading to progressive GN and hematuria.
• Rapidly progressive (crescentic) GN – severe, often immune‑mediated, leading to rapid loss of kidney function.
• Infection‑related GN caused by hepatitis B, hepatitis C, HIV, or COVID‑19.
• Drug‑induced GN – certain antibiotics (penicillins), NSAIDs, or herbal supplements can provoke immune reactions.

References: KDIGO Clinical Practice Guidelines; CDC (post‑infectious GN); NIH.

Associated Symptoms

While hematuria may be the first noticeable sign, most patients experience additional symptoms that reflect kidney dysfunction or the underlying disease process:

• Proteinuria – foamy urine or a positive dip‑stick test for protein.
• Edema – swelling of the ankles, feet, face, or around the eyes, especially in the morning.
• Hypertension – new‑onset or worsening high blood pressure.
• Decreased urine output or feeling of incomplete emptying.
• Painful flank or abdominal discomfort – may indicate kidney capsule stretch.
• Fatigue, weakness, or malaise – result of anemia or buildup of waste products.
• Fever, rash, or joint pain – suggest systemic autoimmune causes (e.g., lupus, vasculitis).
• Respiratory symptoms – cough or coughing up blood in Goodpasture syndrome.

When to See a Doctor

Any new or unexplained hematuria warrants medical evaluation, but there are particular scenarios that require prompt attention:

• Visible pink or red urine that persists for more than 24 hours.
• Accompanying symptoms such as fever, severe flank pain, or a rapid rise in blood pressure.
• Recent history of a streptococcal infection, skin infection, or COVID‑19.
• Known kidney disease or autoimmune disorder with a sudden change in urine color.
• Swelling of the legs, face, or hands that appears rapidly.
• Decreased urine output or inability to urinate.

If you notice any of these signs, schedule an appointment with your primary care physician or a nephrologist (kidney specialist) as soon as possible.

Diagnosis

Diagnosing glomerulonephritis‑related hematuria involves a stepwise approach that combines clinical evaluation, laboratory testing, imaging, and sometimes a kidney biopsy.

1. Medical History & Physical Exam

• Recent infections, medication use, family history of kidney disease.
• Blood pressure measurement, assessment for edema, and listening for heart or lung findings.

2. Laboratory Tests

• Urinalysis – detects red blood cells, casts, protein, and sediment patterns.
• Urine microscopy – red‑cell casts are highly suggestive of glomerular bleeding.
• Blood tests – serum creatinine, BUN, electrolytes, complement levels (C3, C4), anti‑GBM antibodies, ANCA, anti‑nuclear antibodies (ANA), and hepatitis serologies.
• Quantitative protein measurement – urine protein‑to‑creatinine ratio or 24‑hour collection.
• Complete blood count – evaluates anemia from chronic blood loss.

3. Imaging

• Renal ultrasound – assesses kidney size, rules out obstruction or stones.
• In selected cases, CT or MRI may be used to evaluate vascular or structural anomalies.

4. Kidney Biopsy

When non‑invasive tests cannot determine the cause, a percutaneous biopsy is performed. It provides definitive histologic diagnosis, guides therapy, and predicts prognosis.

5. Additional Tests for Specific Causes

• Streptococcal antibody titers (ASO, anti‑DNAse B) for post‑infectious GN.
• Genetic testing for Alport syndrome when a hereditary pattern is suspected.
• Chest imaging if pulmonary hemorrhage is a concern (Goodpasture).

References: KDIGO 2023 GN Guideline; Cleveland Clinic; UpToDate.

Treatment Options

Therapy is tailored to the underlying cause, severity of kidney involvement, and patient’s overall health. Treatment generally falls into two categories: disease‑specific medical therapy and supportive/home measures.

1. Disease‑Specific Medical Therapy

• Immunosuppression – corticosteroids (prednisone) are first‑line for many immune‑mediated GN; additional agents may include cyclophosphamide, mycophenolate mofetil, azathioprine, or rituximab depending on the subtype.
• Plasma exchange (plasmapheresis) – indicated for rapidly progressive GN, anti‑GBM disease, or severe ANCA‑associated vasculitis.
• Targeted antibiotics – for post‑infectious GN; eradication of the inciting organism is essential.
• Complement inhibitors – eculizumab for atypical hemolytic uremic syndrome (a cause of GN).
• Renin‑angiotensin‑aldosterone system (RAAS) blockers – ACE inhibitors or ARBs reduce proteinuria and protect kidney function.

2. Supportive & Home Treatments

• Blood pressure control – aim for <120/80 mmHg if tolerated; home BP monitoring is useful.
• Low‑salt diet – ≤2 g sodium per day to limit fluid retention.
• Fluid management – maintain adequate hydration but avoid excesses if edema or reduced kidney function is present.
• Protein intake – moderate (0.6–0.8 g/kg body weight) for chronic GN; consult a renal dietitian.
• Avoid nephrotoxic agents – NSAIDs, high‑dose vitamin C, certain herbal supplements, and contrast dyes without pre‑hydration.
• Vaccinations – influenza and pneumococcal vaccines reduce infection‑related relapses.

Regular follow‑up labs (every 3–6 months) are essential to monitor response and adjust therapy.

Prevention Tips

While some forms of GN are inevitable (genetic), many triggers are modifiable:

• Prompt treatment of streptococcal throat or skin infections; complete antibiotic courses.
• Practice good hand hygiene and avoid sharing personal items to reduce infection spread.
• Control blood pressure, diabetes, and cholesterol – these conditions hasten kidney damage.
• Limit alcohol and quit smoking; both worsen hypertension and immune dysregulation.
• Avoid unnecessary NSAIDs; use acetaminophen for mild pain when possible.
• Stay up‑to‑date on vaccinations (flu, COVID‑19, hepatitis B) to lower risk of infection‑triggered GN.
• If a family history of hereditary GN (e.g., Alport) exists, consider genetic counseling.
• Maintain a balanced diet rich in fruits, vegetables, and whole grains while limiting processed foods high in sodium.

Emergency Warning Signs

Summary

Glomerulonephritis‑related hematuria is a key clinical clue that the kidneys’ filtering structures are inflamed or damaged. A broad spectrum of diseases—from common post‑streptococcal infections to systemic autoimmune disorders—can produce this finding. Recognizing associated symptoms, seeking timely medical evaluation, and undergoing appropriate laboratory and imaging studies are essential steps toward an accurate diagnosis.

Treatment hinges on identifying the underlying cause and may involve immunosuppressive medications, plasma exchange, or antibiotics, complemented by lifestyle measures that protect kidney function. While certain hereditary forms cannot be prevented, many triggers are avoidable through infection control, blood‑pressure management, and avoidance of nephrotoxic substances.

Because unchecked GN can progress to chronic kidney disease or even renal failure, patients should be vigilant for warning signs and contact healthcare providers promptly. With early detection and tailored therapy, most people achieve disease control and preserve kidney health.

References:

• Mayo Clinic. “Glomerulonephritis.” https://www.mayoclinic.org/diseases‑conditions/glomerulonephritis/diagnosis‑treatment
• National Kidney Foundation. “Hematuria (Blood in the Urine).” https://www.kidney.org/atoz/content/hematuria
• Kidney Disease: Improving Global Outcomes (KDIGO). 2023 Clinical Practice Guideline for Glomerular Diseases.
• Cleveland Clinic. “IgA Nephropathy (Berger Disease).” https://my.clevelandclinic.org/health/diseases/16856-iga-nephropathy
• Centers for Disease Control and Prevention. “Post‑streptococcal Glomerulonephritis.” https://www.cdc.gov/diseases‑conditions/post‑streptococcal‑gn
• NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Lupus Nephritis.” https://www.niddk.nih.gov/health‑information/kidney‑disease/lupus‑nephritis
• World Health Organization. “Vaccines and Immunization for Preventing Infections Associated with GN.”

```